DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 137 mcg recall — FDA D-258-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
10,690drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 425
10,690 detailed records are currently available in this category.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 175 mcg recall — FDA D-260-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 200 mcg recall — FDA D-261-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Actavis South Atlantic buPROPion Hydrochloride Extended-Release Tablets (XL) 300 mg recall — FDA D-248-2013
Failed USP Dissolution Test Requirements: Out-of-specification dissolution results at the 8 hour stability testing point.
Class IIIFDA: TerminatedActavis South Atlantic LLC
DrugApr 17, 2013
Jolessa recall — FDA D-246-2013
Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
Class IIIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 17, 2013
Cefdinir for Oral Suspension, 125 mg/5 mL recall — FDA D-247-2013
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 17, 2013
Portia recall — FDA D-245-2013
Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
Class IIIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 17, 2013
Gsms LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP, 20 mg/25 mg, 100 (NDC 60429-046-01) recall — FDA D-244-2013
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the manufacturer
Class IIFDA: TerminatedGsms
DrugApr 10, 2013
West-ward Pharmaceutical Ethambutol Hydrochloride Tablets, USP, 100 mg, 100-count tablets recall — FDA D-242-2013
Subpotent Drug: Out Of Specification results for assay at the stability time-point of 24 months.
Class IIFDA: TerminatedWest-ward Pharmaceutical Corp.
DrugApr 10, 2013
Palmer Natural Products Aniracetam and Choline, Aniracetam 460 mg, Choline 76 mg, 180 recall — FDA D-232-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
DrugApr 10, 2013
Dr Reddys Laboratories Tennessee Amoxicillin for Oral Suspension, 125mg/5mL, a) 80 mL recall — FDA D-239-2013
Microbial Contamination of Non-Sterile Products: Suspensions made from these lots of Amoxicillin 125 mg/5 mL showed yeast and mold growth at the 14 day time point.
Class IIFDA: TerminatedDr Reddys Laboratories Tennessee LLC
DrugApr 10, 2013
Palmer Natural Products Brain Defogger, Piracetam 390mg Choline 104mg capsules, 100 count recall — FDA D-234-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
DrugApr 10, 2013
Palmer Natural Products Oxiracetam & Choline , Oxiracetam 460mg Choline 110mg capsules a) 30 recall — FDA D-236-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
DrugApr 10, 2013
Hospira 0.9% Sodium Chloride Injection, USP, 50 mL recall — FDA D-243-2013
Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution…
Class IIFDA: TerminatedHospira Inc.
DrugApr 10, 2013
Palmer Natural Products Aniracetam & Choline capsules, 430mg Aniracetam 88mg Choline, a) 30 recall — FDA D-230-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
DrugApr 10, 2013
Palmer Natural Products NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam recall — FDA D-231-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
DrugApr 10, 2013
Palmer Natural Products BoostYourGrade.com, Piracetam 390mg Choline 104mg capsules, 250 recall — FDA D-235-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
DrugApr 10, 2013
Teva Pharmaceuticals USA CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets recall — FDA D-237-2013
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 10, 2013
Palmer Natural Products Piracetam & Choline, 390mg Piracetam 104mg Choline Capsules, a) 30 recall — FDA D-233-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
DrugApr 10, 2013
KETOCONAZOLE Fougera Ketoconazole Cream 2%, 15g tube recall — FDA D-241-2013
Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant…
Class IIIFDA: TerminatedFougera Pharmaceuticals Inc.
DrugApr 10, 2013
Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle recall — FDA D-238-2013
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
Class IIIFDA: TerminatedDr. Reddy'S Laboratories
DrugApr 10, 2013
Ferring Pharmaceuticals TEV-TROPIN (somatropin (rDNA origin) for injection) 5 mg (15 IU) recall — FDA D-240-2013
Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A
Class IIIFDA: TerminatedFerring Pharmaceuticals Inc.
DrugApr 3, 2013
CareFusion 213 SEPP 10% Povidone Iodine Solution USP recall — FDA D-226-2013
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Class IIFDA: TerminatedCareFusion 213, LLC
DrugApr 3, 2013
CareFusion 213 Donor Prep Kit containing 1 FREPP (70% isopropyl alcohol), Net 1.1 mL and 1 recall — FDA D-228-2013
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Class IIFDA: TerminatedCareFusion 213, LLC
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.